	Prevalence and impact of chronic joint diseases on the sexual sphere compared to a healthy population: A multicenter cross-sectional study. Reumatol Clin (Engl Ed) Valera-Ribera C, Alegre-Sancho JJ, Martínez-Ferrer À, Robustillo-Villarino M. PMID: 41390230 [PubMed - indexed for MEDLINE]
	Glucagon-like peptide-1 receptor agonist therapy in patients with psoriasis is associated with decreased risk of psoriatic arthritis: A retrospective cohort study from TriNetX database. J Am Acad Dermatol Hsiao YW, Huang YC. PMID: 41390127 [PubMed - as supplied by publisher]
	Association between the Frailty Index and psoriasis: a cross-sectional study of the U.S. NHANES 2003-2006. J Frailty Aging Wang X, Weng W, Yan Z, Zhang M, Li J, Song B, Gao Y. PMID: 41389199 [PubMed - as supplied by publisher]
	Treatment Preferences Among Systemic Therapy-NaÃ¯ve Patients with Atopic Dermatitis or Psoriasis in Germany: A Multicentre Study. Dermatol Ther (Heidelb) Royeck S, Bamidis AD, Weckbecker C, Hofmann SC, Ständer S, Novak N, Balakirski G, Wilsmann-Theis D. PMID: 41389139 [PubMed - as supplied by publisher]
	The role of phototherapy in reducing the risk of psoriatic arthritis among psoriasis patients in the era of biologics - A single center exploratory retrospective cohort study. J Dtsch Dermatol Ges Bar D, Baum S, Barzilai A, Pavlotsky F, Lozinski A, Lidar M. PMID: 41388476 [PubMed - as supplied by publisher]
	Hesperidin methyl chalcone alleviates imiquimod-induced psoriasis in mice: effects alone and in combination with methotrexate. Naunyn Schmiedebergs Arch Pharmacol Abdelrahman HW, Kadry SM, Morsy WA, Hassen MT. PMID: 41387647 [PubMed - as supplied by publisher]
	Comment on "Comparative risk of reactivation of hepatitis B and C after treatment with biologics and targeted synthetic DMARDs in psoriasis and psoriatic arthritis: a 15-year multicenter cohort study". J Am Acad Dermatol Zhuang Z, Huang J, Zhou X, Feng Y, Chi H. PMID: 41386355 [PubMed - as supplied by publisher]
	Re: Comparative risk of reactivation of hepatitis B and C after treatment with biologics and targeted synthetic DMARDs in psoriasis and psoriatic arthritis: a 15-year multicentre cohort study. J Am Acad Dermatol Maheshwari G, Talha M, Irshad NUN, Hassan M. PMID: 41386354 [PubMed - as supplied by publisher]
	Barriers and facilitators to adopting health-promoting lifestyles in patients with psoriasis in China: a qualitative study using the COM-B and SEM. Front Public Health Xing L, Yu H, Wang S, Huang S, Liu H, Song J. PMID: 41383304 [PubMed - indexed for MEDLINE]
	Bimekizumab Efficacy and Safety in Patients with Psoriatic Arthritis with Substantial Skin and Nail Psoriasis to 1Â Year. Dermatol Ther (Heidelb) Thaçi D, Asahina A, Boehncke WH, Gottlieb AB, Lebwohl M, Warren RB, Edens H, Ink B, Bajracharya R, Coarse J, Merola JF. PMID: 41381988 [PubMed - as supplied by publisher]
	A randomized phase 2 clinical trial to treat moderate-to-severe plaque psoriasis patients with high-induction dosing of risankizumab. Nat Commun Blauvelt A, Jiang R, Shi L, Tsoi LC, Bogle R, Fox J, Gharaee-Kermani M, Billi AC, Matheson RT, Photowala H, Gudjonsson JE, Ehst BD. PMID: 41381642 [PubMed - as supplied by publisher]
	From skin to spinal Cord: How IL-17a Drives psoriatic chronic itch. Brain Behav Immun Liu X, Jiang J, Lin S, Ge W, Tao Q, Liu S, Zhanmu O, Yang Y, Chai B, Zhang J, Li M, Chen H. PMID: 41381012 [PubMed - as supplied by publisher]
	Sleep Disorders in Psoriasis and the Effect of Treatment on Sleep Quality: A Prospective Study in a Resource Poor Setting. Indian Dermatol Online J Hazarika N, Bhatia R, Sarkar N, Vasisht S, Kansal NK, Gupta R. PMID: 41379581 [PubMed - as supplied by publisher]
	What is the optimal sequential therapy after secondary IL-17A inhibitor failure in psoriasis: switching to an IL-23 inhibitor or to another IL-17A inhibitor? J Dermatolog Treat Liu Y, Hu K, Duan Y, Chen J, Liu P, Zhou S, Zhang M, Kuang Y. PMID: 41376531 [PubMed - indexed for MEDLINE]
	Discrimination of Rheumatoid and Psoriatic Arthritis Based on Raman and NIR Spectra Using Machine-Learning Algorithms. Molecules Cuprych P, Kokot I, Szostak R, Kratz EM, Mazurek S. PMID: 41375111 [PubMed - indexed for MEDLINE]
	Lights and Shadows of Nutrient-Driven Keratinocyte Inflammation in Psoriasis. Int J Mol Sci Speranza D, Pantano A, Cullotta C, Pallio G, Vaccaro M, Scuruchi M, Irrera N. PMID: 41373800 [PubMed - indexed for MEDLINE]
	Drug Stratification Based on Real-World Evidence in Psoriasis: A Narrative Review. Dermatol Ther (Heidelb) Sindrup WG, Birk Nielsen A, Kvist-Hansen A, Skov L. PMID: 41372601 [PubMed - as supplied by publisher]
	Generalized pustular psoriasis: review and consensus of the Psoriasis Group of the Spanish Academy of Dermatology and Venereology. Actas Dermosifiliogr Puig L, Carrascosa JM, Rivera R, Vilarrasa E, de la Cueva P, López-Ferrer A. PMID: 41371399 [PubMed - as supplied by publisher]
	Nutrition and Psoriasis: The Latest Evidence and How to Approach Nutrition in Clinical Practice. Am J Clin Dermatol Leung A, Kranyak A, Marquez-Grap G, Bhutani T. PMID: 41369865 [PubMed - as supplied by publisher]
	The impact of apremilast on cardiometabolic and inflammation indexes in psoriatic patients at high cardiovascular risk: A real-world multicenter retrospective observational study. J Am Acad Dermatol Raimondo A, Megna M, Donnarumma M, Lembo S, Nicoletti MM, Romano F, Sarno O, Di Luzio GS, Balato A. PMID: 41369607 [PubMed - as supplied by publisher]

Articles 1 - 20 / 27166

Page 1 of 1359



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy